OTOTOXICITY

Clinical trials for OTOTOXICITY explained in plain language.

Never miss a new study

Get alerted when new OTOTOXICITY trials appear

Sign up with your email to follow new studies for OTOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 3

New pill aims to stop chemo from stealing hearing

Prevention Terminated

This study was designed to test whether an oral drug called SPI-1005 could prevent hearing loss and ringing in the ears caused by platinum-based chemotherapy. It was planned for adults with advanced lung or head and neck cancer. The study was withdrawn before enrolling any partic…

Matched conditions: OTOTOXICITY

Phase: PHASE2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Prevention

Last updated Jun 27, 2026 13:01 UTC

OTOTOXICITY

Get alerted when new OTOTOXICITY trials appear

New pill aims to stop chemo from stealing hearing